U.S. retail investor fund flows into Novo Nordisk surged 32-fold on Friday, as the Danish drugmaker's weaker-than-expected ...

Novo Nordisk has an opportunity to expand indications on its weight loss drugs. Check out on what could be next for NVO stock ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Among the many newcomers to the business of weight-loss drugs is Hims & Hers, an American e-pharmacy better known for hawking ...

The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved ...

Just one hour left in the shortened holiday trading session, so let Brad Smith and Josh Lipton lead you into the Christmas season by covering the biggest market stories heading into the closing bell.

The FDA initially rejected the marketing application for Alhemo in 2022, asking for additional data on dosing and monitoring.

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 502.93% and ...

Pfizer's oncology promises are several years from being actualized. Read why investors shouldn't assume that a sustained ...

Phuket is a province in the south of Thailand. Phuket's beaches face the Andaman Sea allowing the west coast beaches fantastic sunsets right throughout the year. If ...